1027368

Emily A. DiMango, M.D. — FEI 3013753808

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 2, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance